drugset / Trial / NCT01560507
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to ascertain: 1) the rate of smoking cessation obtained using an adaptive treatment algorithm developed in previous clinical trials, in order to calculate cost-effectiveness of the treatment; 2) the relationship between genotype and response to cigarette smoking cessation treatment.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupropion | Small molecule | 150 mg | — |
| Comparator | Nicotine | Unknown | 21 mg | Other |
| Comparator | Varenicline | Small molecule | 1 mg | — |